Swiss Medica is offering access to Multiple Sclerosis stem cell therapy. This Multiple Sclerosis Treatment are being studied for their efficacy in improving the complications in patients with MS, through the use of stem cells.
Showing posts with label stem cell therapy uk. Show all posts
Showing posts with label stem cell therapy uk. Show all posts
According statistical reports in there is 100.000 people affected by Multiple Sclerosis in the UK, also this disease affects around 2.5. million people around the world. When
looking at the UK alone, increase in number of multiple sclerosis patients in UK is troublesome.
One in every 600 residents live with this condition, whilst 100 new individuals
are diagnosed each week.
Swiss MedicaMultiple Sclerosis Treatment are being studied for their
efficacy in improving the complications inpatients with MS, through the use of
stem cells. These procedures may help patients who don’t respond to
typical drug treatment, want to reduce their reliance on medication or are looking
to try stem cell therapy before starting drug treatment.
This stem cell treatmentis designed to target the myelin
sheath by introducing adult mesenchymal stem cells past the blood brain barrier
so they may differentiate into and repair the myelin sheath nerve cells.
Multiple Sclerosis is an auto-immune condition, adipose derived mesenchymal
stem cells have the ability to repair the immune system; keeping it from
attacking itself.
The procedure is completely safe,
painless and quick. Stem cells used for treatment are taken from patient’s own
body, therefore eliminating any possible side effects or rejections. They are
extracted from either adipose tissue or bone marrow. After being medically
treated, stem cells are ready to be transferred to patient’s organism.
This new treatment helps patients suffering from Multiple Sclerosis, to reduce their MS symptoms, and also to improve overall health condition.
As a cure for MS is not find yet, this new treatment shows very good results.
